204 related articles for article (PubMed ID: 33781501)
1. Pediatric Gliomas: Molecular Landscape and Emerging Targets.
Peeters SM; Muftuoglu Y; Na B; Daniels DJ; Wang AC
Neurosurg Clin N Am; 2021 Apr; 32(2):181-190. PubMed ID: 33781501
[TBL] [Abstract][Full Text] [Related]
2. [Pediatric Glioma].
Terashima K; Ogiwara H
No Shinkei Geka; 2021 May; 49(3):640-646. PubMed ID: 34092570
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers and targeted therapy in pediatric low-grade glioma.
de Blank P; Fouladi M; Huse JT
J Neurooncol; 2020 Oct; 150(1):5-15. PubMed ID: 32399739
[TBL] [Abstract][Full Text] [Related]
4. Pediatric low-grade glioma in the era of molecular diagnostics.
Ryall S; Tabori U; Hawkins C
Acta Neuropathol Commun; 2020 Mar; 8(1):30. PubMed ID: 32164789
[TBL] [Abstract][Full Text] [Related]
5. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
6. Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.
Misove A; Vicha A; Broz P; Vanova K; Sumerauer D; Stolova L; Sramkova L; Koblizek M; Zamecnik J; Kyncl M; Holubova Z; Liby P; Taborsky J; Benes V; Pernikova I; Jones DTW; Sill M; Stancokova T; Krskova L; Zapotocky M
Acta Neuropathol Commun; 2022 Sep; 10(1):143. PubMed ID: 36163281
[TBL] [Abstract][Full Text] [Related]
7. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
[TBL] [Abstract][Full Text] [Related]
8. Characterization of gliomas: from morphology to molecules.
Ferris SP; Hofmann JW; Solomon DA; Perry A
Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
[TBL] [Abstract][Full Text] [Related]
9. BRAF Inhibition in
Kaley T; Touat M; Subbiah V; Hollebecque A; Rodon J; Lockhart AC; Keedy V; Bielle F; Hofheinz RD; Joly F; Blay JY; Chau I; Puzanov I; Raje NS; Wolf J; DeAngelis LM; Makrutzki M; Riehl T; Pitcher B; Baselga J; Hyman DM
J Clin Oncol; 2018 Dec; 36(35):3477-3484. PubMed ID: 30351999
[TBL] [Abstract][Full Text] [Related]
10. Preclinical therapeutic targets in diffuse midline glioma.
Meel MH; Kaspers GJL; Hulleman E
Drug Resist Updat; 2019 May; 44():15-25. PubMed ID: 31202081
[TBL] [Abstract][Full Text] [Related]
11. Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy.
Graham MS; Mellinghoff IK
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003625
[TBL] [Abstract][Full Text] [Related]
12. Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.
Garcia MA; Solomon DA; Haas-Kogan DA
Future Oncol; 2016 Jun; 12(12):1493-506. PubMed ID: 27072750
[TBL] [Abstract][Full Text] [Related]
13. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
[TBL] [Abstract][Full Text] [Related]
14. Approaches toward improving the prognosis of pediatric patients with glioma: pursuing mutant drug targets with emerging small molecules.
Snape TJ; Warr T
Semin Pediatr Neurol; 2015 Mar; 22(1):28-34. PubMed ID: 25976258
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of gliomas: potential therapeutic implications.
Alentorn A; Duran-Peña A; Pingle SC; Piccioni DE; Idbaih A; Kesari S
Expert Rev Anticancer Ther; 2015; 15(8):955-62. PubMed ID: 26118895
[TBL] [Abstract][Full Text] [Related]
17. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Low-Grade Gliomas.
Collins KL; Pollack IF
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32375301
[TBL] [Abstract][Full Text] [Related]
19. EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors.
Rudà R; Capper D; Waldman AD; Pallud J; Minniti G; Kaley TJ; Bouffet E; Tabatabai G; Aronica E; Jakola AS; Pfister SM; Schiff D; Lassman AB; Solomon DA; Soffietti R; Weller M; Preusser M; Idbaih A; Wen PY; van den Bent MJ
Neuro Oncol; 2022 Dec; 24(12):2015-2034. PubMed ID: 35908833
[TBL] [Abstract][Full Text] [Related]
20. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]